Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Vishal Patel

As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at the optimal time during the course of their disease, according to Vishal Patel, MD, FAAD, FACMS.

Read the OncLive® article.

Latest News

The paths that led Rowan Schmincke to the GW Cancer Center felt, to her, very varied and circuitous. At times, she wondered where she was going. Ultimately, those paths converged at Foggy Bottom, where her work as an oncology clinical research nurse is helping to discover cutting-edge solutions in…
James Rao's toolbox is filled with some of the most technical devices medicine has to offer. As one of the GW Cancer Center's radiation oncologists, Dr. Rao may perform stereotactic radiosurgery on one patient and brachytherapy on the next. His goal is to be as minimally invasive as possible and to…
A cancer diagnosis is an earth-shattering event, not just for the person diagnosed but for everyone who loves them. It sets off a cascade of emotions — fear, anger, sadness, and grief.